Table 1 Patient demographic and clinical characteristics
From: Measuring interictal burden among people affected by migraine: a descriptive survey study
Characteristic | Overall, N = 506 | US, n = 257 | Germany, n = 249 |
|---|---|---|---|
Age (years), mean (SD) | 45.0 (13.8) | 44.8 (14.7) | 45.2 (12.9) |
Sex | |||
 Male | 184 (36%) | 110 (43%) | 74 (30%) |
 Female | 322 (64%) | 147 (57%) | 175 (70%) |
Employment status | |||
 Employed part−/full-time | 341 (67%) | 173 (67%) | 168 (67%) |
 Retired | 96 (19%) | 48 (19%) | 48 (19%) |
 Other | 69 (14%) | 36 (14%) | 33 (13%) |
Disease duration (years)a, mean (SD) | 18.2 (14.9) | 16.5 (15.0) | 20.0 (14.6) |
Chronic migraine (ever diagnosed) | 239 (47%) | 148 (58%) | 91 (37%) |
Monthly migraine days, mean (SD) | 8.7 (6.4) | 10.6 (6.8) | 6.7 (5.2) |
Monthly headache days, mean (SD) | 10.6 (7.1) | 12.2 (7.7) | 8.8 (6.0) |
Preventive treatment (non-CGRP mAb) | |||
 In the last 3 months | 217 (43%) | 125 (49%) | 92 (37%) |
 In the past | 141 (28%) | 84 (33%) | 57 (23%) |
 Never | 148 (29%) | 48 (19%) | 100 (40%) |
CGRP mAb treatment | |||
 In the last 3 months | 83 (16%) | 52 (20%) | 31 (12%) |
 In the past | 112 (22%) | 78 (30%) | 34 (14%) |
 Never | 311 (61%) | 127 (49%) | 184 (74%) |
Satisfied with treatment regimenb | |||
 No | 297 (59%) | 151 (59%) | 146 (59%) |
 Yes | 209 (41%) | 106 (41%) | 103 (41%) |
Other chronic health condition – any (yes) | 354 (70%) | 197 (77%) | 157 (63%) |
 Physical health condition | 232 (46%) | 137 (53%) | 95 (38%) |
 Mental health condition | 227 (45%) | 130 (51%) | 97 (39%) |
  Anxiety | 159 (31%) | 109 (42%) | 50 (20%) |
  Depression | 148 (29%) | 77 (30%) | 71 (29%) |
  Other | 123 (24%) | 64 (25%) | 59 (24%) |